Luye Pharma Group Ltd.
Luye Pharma Group Ltd. (LYPHF) Stock Competitors & Peer Comparison
See (LYPHF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LYPHF | $0.38 | +0.00% | 1.5B | 18.88 | $0.02 | N/A |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.26% |
| RHHBF | $419.50 | -3.55% | 346.2B | 21.21 | $20.51 | +2.93% |
| RHHBY | $51.75 | -0.21% | 332.8B | 20.19 | $2.56 | +3.08% |
| RHHVF | $403.29 | +8.69% | 321B | 19.92 | $20.25 | +3.09% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $145.00 | -0.02% | 276.7B | 20.31 | $7.14 | +3.28% |
| SNYNF | $92.44 | +0.00% | 110.9B | 19.88 | $4.65 | +4.74% |
| GLAXF | $27.21 | +0.00% | 108.7B | 14.55 | $1.87 | +3.24% |
| CHGCY | $27.22 | -2.37% | 89.9B | 32.92 | $0.83 | +3.01% |
Stock Comparison
LYPHF vs BMYMP Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, LYPHF is priced at $0.38, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, LYPHF's ROE is +0.04%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, LYPHF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check BMYMP's competition here
LYPHF vs RHHBF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, RHHBF has a market cap of 346.2B. Regarding current trading prices, LYPHF is priced at $0.38, while RHHBF trades at $419.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas RHHBF's P/E ratio is 21.21. In terms of profitability, LYPHF's ROE is +0.04%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, LYPHF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check RHHBF's competition here
LYPHF vs RHHBY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, RHHBY has a market cap of 332.8B. Regarding current trading prices, LYPHF is priced at $0.38, while RHHBY trades at $51.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas RHHBY's P/E ratio is 20.19. In terms of profitability, LYPHF's ROE is +0.04%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, LYPHF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check RHHBY's competition here
LYPHF vs RHHVF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, LYPHF is priced at $0.38, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas RHHVF's P/E ratio is 19.92. In terms of profitability, LYPHF's ROE is +0.04%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, LYPHF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check RHHVF's competition here
LYPHF vs AZNCF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, LYPHF is priced at $0.38, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, LYPHF's ROE is +0.04%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, LYPHF is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check AZNCF's competition here
LYPHF vs NVSEF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, NVSEF has a market cap of 276.7B. Regarding current trading prices, LYPHF is priced at $0.38, while NVSEF trades at $145.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas NVSEF's P/E ratio is 20.31. In terms of profitability, LYPHF's ROE is +0.04%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, LYPHF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check NVSEF's competition here
LYPHF vs SNYNF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, SNYNF has a market cap of 110.9B. Regarding current trading prices, LYPHF is priced at $0.38, while SNYNF trades at $92.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas SNYNF's P/E ratio is 19.88. In terms of profitability, LYPHF's ROE is +0.04%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, LYPHF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check SNYNF's competition here
LYPHF vs GLAXF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, GLAXF has a market cap of 108.7B. Regarding current trading prices, LYPHF is priced at $0.38, while GLAXF trades at $27.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas GLAXF's P/E ratio is 14.55. In terms of profitability, LYPHF's ROE is +0.04%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, LYPHF is less volatile compared to GLAXF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check GLAXF's competition here
LYPHF vs CHGCY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CHGCY has a market cap of 89.9B. Regarding current trading prices, LYPHF is priced at $0.38, while CHGCY trades at $27.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CHGCY's P/E ratio is 32.92. In terms of profitability, LYPHF's ROE is +0.04%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, LYPHF is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check CHGCY's competition here
LYPHF vs CHGCF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CHGCF has a market cap of 89B. Regarding current trading prices, LYPHF is priced at $0.38, while CHGCF trades at $54.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CHGCF's P/E ratio is 32.59. In terms of profitability, LYPHF's ROE is +0.04%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, LYPHF is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check CHGCF's competition here
LYPHF vs BAYRY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, BAYRY has a market cap of 44.1B. Regarding current trading prices, LYPHF is priced at $0.38, while BAYRY trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas BAYRY's P/E ratio is -10.40. In terms of profitability, LYPHF's ROE is +0.04%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, LYPHF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check BAYRY's competition here
LYPHF vs OTSKF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, OTSKF has a market cap of 37B. Regarding current trading prices, LYPHF is priced at $0.38, while OTSKF trades at $69.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas OTSKF's P/E ratio is 16.27. In terms of profitability, LYPHF's ROE is +0.04%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, LYPHF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check OTSKF's competition here
LYPHF vs OTSKY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, OTSKY has a market cap of 35.7B. Regarding current trading prices, LYPHF is priced at $0.38, while OTSKY trades at $33.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas OTSKY's P/E ratio is 15.74. In terms of profitability, LYPHF's ROE is +0.04%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, LYPHF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check OTSKY's competition here
LYPHF vs DSKYF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, DSKYF has a market cap of 30B. Regarding current trading prices, LYPHF is priced at $0.38, while DSKYF trades at $16.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas DSKYF's P/E ratio is 17.22. In terms of profitability, LYPHF's ROE is +0.04%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, LYPHF is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check DSKYF's competition here
LYPHF vs DSNKY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, DSNKY has a market cap of 28.8B. Regarding current trading prices, LYPHF is priced at $0.38, while DSNKY trades at $15.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas DSNKY's P/E ratio is 16.57. In terms of profitability, LYPHF's ROE is +0.04%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, LYPHF is less volatile compared to DSNKY. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check DSNKY's competition here
LYPHF vs ALPMF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, ALPMF has a market cap of 27.9B. Regarding current trading prices, LYPHF is priced at $0.38, while ALPMF trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas ALPMF's P/E ratio is 35.45. In terms of profitability, LYPHF's ROE is +0.04%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, LYPHF is less volatile compared to ALPMF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check ALPMF's competition here
LYPHF vs ALPMY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, ALPMY has a market cap of 27.6B. Regarding current trading prices, LYPHF is priced at $0.38, while ALPMY trades at $15.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas ALPMY's P/E ratio is 35.07. In terms of profitability, LYPHF's ROE is +0.04%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, LYPHF is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check ALPMY's competition here
LYPHF vs ORINY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, ORINY has a market cap of 22.3B. Regarding current trading prices, LYPHF is priced at $0.38, while ORINY trades at $39.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas ORINY's P/E ratio is 17.93. In terms of profitability, LYPHF's ROE is +0.04%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, LYPHF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check ORINY's competition here
LYPHF vs GIKLY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, GIKLY has a market cap of 13.6B. Regarding current trading prices, LYPHF is priced at $0.38, while GIKLY trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas GIKLY's P/E ratio is 14.80. In terms of profitability, LYPHF's ROE is +0.04%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, LYPHF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check GIKLY's competition here
LYPHF vs CSPCY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CSPCY has a market cap of 13.1B. Regarding current trading prices, LYPHF is priced at $0.38, while CSPCY trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CSPCY's P/E ratio is 22.60. In terms of profitability, LYPHF's ROE is +0.04%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, LYPHF is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check CSPCY's competition here
LYPHF vs CHJTF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, LYPHF is priced at $0.38, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, LYPHF's ROE is +0.04%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, LYPHF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check CHJTF's competition here
LYPHF vs ORINF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, LYPHF is priced at $0.38, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas ORINF's P/E ratio is 18.72. In terms of profitability, LYPHF's ROE is +0.04%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, LYPHF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check ORINF's competition here
LYPHF vs RCDTF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, RCDTF has a market cap of 11.6B. Regarding current trading prices, LYPHF is priced at $0.38, while RCDTF trades at $56.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas RCDTF's P/E ratio is 22.87. In terms of profitability, LYPHF's ROE is +0.04%, compared to RCDTF's ROE of +0.23%. Regarding short-term risk, LYPHF is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check RCDTF's competition here
LYPHF vs GIFOF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, LYPHF is priced at $0.38, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas GIFOF's P/E ratio is 12.83. In terms of profitability, LYPHF's ROE is +0.04%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, LYPHF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check GIFOF's competition here
LYPHF vs KYKOF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, KYKOF has a market cap of 7.9B. Regarding current trading prices, LYPHF is priced at $0.38, while KYKOF trades at $15.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas KYKOF's P/E ratio is 18.58. In terms of profitability, LYPHF's ROE is +0.04%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, LYPHF is less volatile compared to KYKOF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check KYKOF's competition here
LYPHF vs GIFLF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, GIFLF has a market cap of 7.2B. Regarding current trading prices, LYPHF is priced at $0.38, while GIFLF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas GIFLF's P/E ratio is 15.32. In terms of profitability, LYPHF's ROE is +0.04%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, LYPHF is less volatile compared to GIFLF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check GIFLF's competition here
LYPHF vs OPHLY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, OPHLY has a market cap of 6.9B. Regarding current trading prices, LYPHF is priced at $0.38, while OPHLY trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas OPHLY's P/E ratio is 20.38. In terms of profitability, LYPHF's ROE is +0.04%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, LYPHF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check OPHLY's competition here
LYPHF vs OPHLF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, LYPHF is priced at $0.38, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas OPHLF's P/E ratio is 20.49. In terms of profitability, LYPHF's ROE is +0.04%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, LYPHF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check OPHLF's competition here
LYPHF vs DPHAY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, LYPHF is priced at $0.38, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, LYPHF's ROE is +0.04%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, LYPHF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check DPHAY's competition here
LYPHF vs SNPHF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, LYPHF is priced at $0.38, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas SNPHF's P/E ratio is 18.95. In terms of profitability, LYPHF's ROE is +0.04%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, LYPHF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check SNPHF's competition here
LYPHF vs SNPHY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, SNPHY has a market cap of 3.3B. Regarding current trading prices, LYPHF is priced at $0.38, while SNPHY trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas SNPHY's P/E ratio is 17.88. In terms of profitability, LYPHF's ROE is +0.04%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, LYPHF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check SNPHY's competition here
LYPHF vs VRBCF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, VRBCF has a market cap of 3.2B. Regarding current trading prices, LYPHF is priced at $0.38, while VRBCF trades at $384.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas VRBCF's P/E ratio is 18.15. In terms of profitability, LYPHF's ROE is +0.04%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, LYPHF is less volatile compared to VRBCF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check VRBCF's competition here
LYPHF vs HAWPY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, LYPHF is priced at $0.38, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas HAWPY's P/E ratio is 14.15. In terms of profitability, LYPHF's ROE is +0.04%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, LYPHF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check HAWPY's competition here
LYPHF vs PTKFF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, LYPHF is priced at $0.38, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas PTKFF's P/E ratio is N/A. In terms of profitability, LYPHF's ROE is +0.04%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, LYPHF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check PTKFF's competition here
LYPHF vs HAWPF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, LYPHF is priced at $0.38, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, LYPHF's ROE is +0.04%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, LYPHF is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check HAWPF's competition here
LYPHF vs CMOPF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CMOPF has a market cap of 1.9B. Regarding current trading prices, LYPHF is priced at $0.38, while CMOPF trades at $114.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CMOPF's P/E ratio is -441.85. In terms of profitability, LYPHF's ROE is +0.04%, compared to CMOPF's ROE of -0.01%. Regarding short-term risk, LYPHF is more volatile compared to CMOPF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check CMOPF's competition here
LYPHF vs TGRNF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, LYPHF is priced at $0.38, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, LYPHF's ROE is +0.04%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, LYPHF is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check TGRNF's competition here
LYPHF vs JCRRF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, LYPHF is priced at $0.38, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, LYPHF's ROE is +0.04%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, LYPHF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check JCRRF's competition here
LYPHF vs MAYNF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, MAYNF has a market cap of 143M. Regarding current trading prices, LYPHF is priced at $0.38, while MAYNF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas MAYNF's P/E ratio is -2.38. In terms of profitability, LYPHF's ROE is +0.04%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, LYPHF is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check MAYNF's competition here
LYPHF vs PTKFY Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, PTKFY has a market cap of 11.9M. Regarding current trading prices, LYPHF is priced at $0.38, while PTKFY trades at $10.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas PTKFY's P/E ratio is 11.16. In terms of profitability, LYPHF's ROE is +0.04%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, LYPHF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check PTKFY's competition here
LYPHF vs PSYGF Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, LYPHF is priced at $0.38, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, LYPHF's ROE is +0.04%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, LYPHF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for LYPHF.Check PSYGF's competition here
LYPHF vs CRXTQ Comparison April 2026
LYPHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LYPHF stands at 1.5B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, LYPHF is priced at $0.38, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LYPHF currently has a P/E ratio of 18.88, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, LYPHF's ROE is +0.04%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, LYPHF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for LYPHF.Check CRXTQ's competition here